Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2025-12-24 @ 12:36 PM
NCT ID:
NCT03556761
Eligibility Criteria:
Inclusion Criteria:
* Hypertensive disorder of pregnancy diagnosed antepartum or intrapartum
* Gestational hypertension
* Pre-eclampsia with or without severe features
* Superimposed pre-eclampsia with or without severe features
* New diagnosis of HDP within 24 hours from delivery
* Postpartum, delivery ≥ 20 weeks estimated gestational age
* Age ≥18 years old
Exclusion Criteria:
* History of allergic reaction to furosemide
* High risk comorbidities for which treatment may be indicated or contraindicated: class C or higher diabetes mellitus, chronic kidney disease or baseline creatinine \>1.2, cardiac disorders including cardiomyopathy, congenital heart disease, angina or coronary heart disease, rheumatic disease (lupus), sickle cell disease
* Baseline labs with K \<3
* Use of furosemide or other diuretics antepartum or intrapartum
* Use of ototoxic agents including aminoglycosides (ie, Gentamicin for \>1 dose), cephalosporins (ie Ancef \>1 dose),
* Patient unstable for protocol per investigator's judgement
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03556761
Study Brief:
Protocol Section:
NCT03556761